# St. Antonius Hospital

Organization · id `cardio:org-st-antonius-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 01jvpb595](<https://ror.org/01jvpb595>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 9 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 01jvpb595 by an exact name.

## The registry's words

- Sponsor name: St. Antonius Hospital
- Sponsor class: OTHER
- ROR name: St. Antonius Ziekenhuis

## Connected pages

- Sponsors: Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation (`cardio:ct-nct02247128`)
- Sponsors: Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly (`cardio:ct-nct02317198`)
- Sponsors: Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement (`cardio:ct-nct03121053`)
- Sponsors: What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? (`cardio:ct-nct04436978`)
- Sponsors: Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI) (`cardio:ct-nct04437303`)
- Sponsors: Reduced Anticoagulation Targets in ECLS (RATE) (`cardio:ct-nct04536272`)
- Sponsors: Evaluating Edge-to-edge Transcatheter Tricuspid Valve Repair in Patients With Severe Symptomatic Tricuspid Regurgitation (`cardio:ct-nct05628779`)
- Sponsors: Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation (POPular ACE TAVI) (`cardio:ct-nct05774691`)
- Sponsors: POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy (`cardio:ct-nct05926271`)

## Provenance

Content hash: 7b8233fb7afd8b7e4a113b53b2a4f3fdde8cd24567e3ddb88698160935c2373a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
